1.会议召开时间：2023 年 8 月 29 日 2.会议召开地点：东莞市汉维科技股份有限公司会议室 证券代码：836957 证券简称：汉维科技 公告编号：2023-058 东莞市汉维科技股份有限公司 第三届董事会第十七次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 3.会议召开方式：现场及视频方式 4.发出董事会会议通知的时间和方式：2023 年 8 月 18 日以书面或电子通讯 方式发出 5.会议主持人：周述辉先生 6.会议列席人员：监事及高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议从会议召集、召开、议案审议程序等方面符合《公司法》等法律、 法规、规范性文件以及《公司章程》的规定。 （二）会议出席情况 会议应出席董事 9 人，出席和授权出席董事 9 人。 二、议案审议情况 （一）审议通过《关于公司 2023 年半年度报告及其摘要的议案》 1.议案内容： 根据《中华人民共和国公司法》及《东莞市汉维科技股份有限公司章程》等 相 ...

证券代码：836957 证券简称：汉维科技 公告编号：2023-055 汉维科技 836957 公 司 全 称 （ 中 英 文 ） 公司半年度大事记 公司参加国内外展会剪影 | 156 | 东莞市工程技术研究 中心(公益类) | 大湾区智能传感器工程中心 | 松山湖材料实验室 | 市属 | | --- | --- | --- | --- | --- | | 157 | 东莞市重点实验室 (企业类) | 东莞市高速高精度协作机器人关键技术重点实验室 | 伯朗特机器人股份有限公司 | 大朗镇经济发展局 | | 158 | 东莞市重点实验室 (企业类) | 东莞市特种空调绿色节能技术实验室 | 广东海悟科技有限公司 | 樟木头镇经济发展局 | | 159 | 东莞市重点实验室 (企业类) | 东莞市高分子材料助剂重点实验室 | 东莞市汉维科技股份有限公司 | 桥头镇经济发展局 | | 160 | 东莞市重点实验室 (企业类) | 东莞市光电缆高性能聚合物材料重点实验室 | 广东安拓普聚合物科技有限公司 | 东城街道创新驱动办公室 | 公司实验室获得 "东莞市高分子材料助剂重点实验室"荣誉称号 | 二、市级单项冠军产 ...

公司负责人周述辉、主管会计工作负责人冯妙及会计机构负责人（会计主管人员）冯妙保证季度报 告中财务报告的真实、准确、完整。 证券代码：836957 证券简称：汉维科技 公告编号：2023-050 汉维科技 证券代码 : 836957 东莞市汉维科技股份有限公司 2023 年第一季度报告 1 第一节 重要提示 公司董事、监事、高级管理人员保证本报告所载资料不存在虚假记载、误导性陈述或者重大遗漏，并对 其内容的真实性、准确性和完整性承担个别及连带责任。 财务数据重大变动原因： 本季度报告未经会计师事务所审计。 本季度报告涉及未来计划等前瞻性陈述，不构成公司对投资者的实质承诺，投资者及相关人士均应 对此保持足够的风险认识，并且应当理解计划、预测与承诺之间的差异。 | 事项 | | 是或否 | | --- | --- | --- | | 是否存在公司董事、监事、高级管理人员对季度报告内容存在异议或无法保证其真实、 | □是 | √否 | | 准确、完整 | | | | 是否存在未出席董事会审议季度报告的董事 | □是 | √否 | | 是否存在未按要求披露的事项 | □是 | √否 | | 是否审计 | □是 | √否 ...

证券代码：836957 证券简称：汉维科技 公告编号：2023-047 东莞市汉维科技股份有限公司 2022 年年度报告业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个 别及连带法律责任。 一、 说明会类型 东莞市汉维科技股份有限公司（以下简称"公司"）于 2023 年 3 月 29 日在 北京证券交易所信息披露平台（www.bse.cn）披露了《2022 年年度报告》（公告 编号：2023-027）及《2022 年年度报告摘要》（公告编号：2023-032），为方便广 大投资者更深入了解公司 2022 年年度经营业绩的具体情况，加强与投资者的互 动交流，公司拟召开 2022 年年度报告业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：2023年4月14日（星期五）15:00-17:00 。 （二）会议召开地点 本次年度报告业绩说明会将采用网络方式召开，投资者可登陆全景网"投 资者关系互动平台"（http://ir.p5w.net）参与本次业绩说明会。 三、 参加人员 公司董事长、总经理：周 ...

Financial Performance - The company's operating revenue for 2022 was CNY 487.88 million, a decrease of 7.20% compared to CNY 525.74 million in 2021[29]. - The net profit attributable to shareholders for 2022 was CNY 35.87 million, an increase of 8.87% from CNY 32.94 million in 2021[29]. - The total assets increased by 17.16% to CNY 584.57 million in 2022, up from CNY 498.96 million in 2021[31]. - The total liabilities decreased by 17.03% to CNY 181.61 million in 2022, down from CNY 218.88 million in 2021[31]. - The company's gross profit margin improved to 14.65% in 2022, compared to 13.47% in 2021[29]. - The cash flow from operating activities for 2022 was CNY 63.80 million, a significant increase of 552.21% from a negative CNY 14.11 million in 2021[33]. - The weighted average return on equity based on net profit attributable to shareholders was 12.30% in 2022, down from 12.81% in 2021[29]. - The company reported a basic earnings per share of CNY 0.39 in 2022, an increase of 8.33% from CNY 0.36 in 2021[29]. - The company experienced a net profit growth rate of 7.82% in 2022, compared to a decline of 23.61% in 2021[34]. - The company achieved a total non-recurring profit and loss of 3,346,079.41 in 2022, compared to 4,085,289.64 in 2021, indicating a decline of approximately 18.1%[40]. Production and Capacity Expansion - The company plans to add 60,000 tons of fatty acid salt additives, 25,000 tons of fatty acid esters, 25,000 tons of fatty acid amides, and 10,000 tons of special additives upon completion of its fundraising projects[13]. - The company commenced construction of its environmental additives production project on March 5, 2022[4]. - The company has completed the construction of its environmental additive production project, which began on March 5, 2022[49]. - The company expects continued growth in the PE wood-plastic production capacity, with an annual compound growth rate of 10%-20% projected until 2025[57]. - The company will prioritize market expansion efforts to ensure the timely absorption of new production capacity from fundraising projects[128]. Research and Development - The company holds a total of 30 patents, including 10 invention patents, an increase from 29 patents in the previous period[93]. - The company is in the trial production stage for several R&D projects, including a low-foam grinding aid for UV wood coatings, which aims to address existing processing issues[94]. - A new water-based zinc stearate emulsion is being developed, expected to enhance product performance and support industry upgrades[95]. - The company is working on a low-acid magnesium stearate project aimed at improving competitiveness in the pharmaceutical-grade market[96]. - The development of a high-solid content calcium stearate lubricant is underway, which is anticipated to yield two new products and improve market competitiveness[96]. - The company has initiated projects to produce high-performance PVC wallboard materials and organic auxiliary heat stabilizers, aligning with sustainable development strategies[96]. Risk Management - The company faces risks related to the inability to fully pass on raw material price increases to downstream customers[12]. - The company’s operating performance is subject to significant fluctuations due to raw material price volatility[12]. - The company has identified a new risk regarding the absorption of additional production capacity from fundraising projects[13]. - The company faces risks from raw material price fluctuations, particularly for stearic acid, which is influenced by palm oil prices[117]. - The company has established a strategic cooperation model with stable suppliers to mitigate the impact of raw material price volatility[118]. Corporate Governance and Compliance - The company has committed to fulfilling its corporate social responsibility by adhering to laws, protecting the environment, and providing employment opportunities[110]. - The company has no significant impact on its financial status or operating results from the recent accounting policy changes[105][106]. - The company has completed the deregistration of Dongguan Han Innovation Materials Technology Co., Ltd. as of October 21, 2022[109]. - The company emphasizes the importance of risk management and aims to enhance its resilience through the implementation of investment projects[113]. - The company has not reported any unprofitable situations or cumulative losses during the reporting period[111]. Stock and Shareholder Management - The company's stock was listed on the Beijing Stock Exchange on December 14, 2022[5]. - The company is currently fulfilling commitments related to stabilizing stock prices after its listing, which includes measures to address stock price dips below net asset value[135]. - The company has committed to strict adherence to profit distribution regulations as per its articles of association and relevant laws[134]. - The company will enhance the management of raised funds to ensure their safe and effective use, thereby protecting the interests of investors, especially small and medium-sized investors[154]. - The company will accept social supervision and implement strict measures to ensure the fulfillment of commitments, including timely public explanations for any failures[160]. Financial Strategy and Investment - The company plans to use up to CNY 87 million of idle raised funds for cash management to enhance efficiency[25]. - The company will increase investment in product research and development to accelerate the conversion of R&D results and enhance sales scale and profitability[156]. - A cost management strategy will be implemented to control expenses and improve profit margins, with specific optimization tasks assigned to various departments[156]. - The company commits to fulfilling measures to compensate for any dilution of immediate returns, and if not fulfilled, will publicly explain the reasons and apologize to shareholders[159].

证券代码：836957 证券简称：汉维科技 公告编号：2023-015 东莞市汉维科技股份有限公司 2022 年年度业绩快报公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 特别提示：本公告所载 2022 年年度主要财务数据为初步核算数据，未经会 计师事务所审计，具体数据以公司 2022 年年度报告中披露的数据为准，提请投 资者注意投资风险。 三、风险提示 单位：元 项目 本报告期 上年同期 变动比例% 营业收入 487,880,357.88 525,743,824.96 -7.20% 归属于上市公司股 东的净利润 35,929,801.88 32,943,579.66 9.06% 归属于上市公司股 东的扣除非经常性 损益的净利润 33,065,672.40 29,469,636.97 12.20% 基本每股收益 0.39 0.36 8.33% 加权平均净资产收 益率%（扣非前） 12.32% 12.81% - 加权平均净资产收 益率%（扣非后） 11.34% 11.46% - 本报告期末 本报告期 ...